Assertio(us:ASRT)

    0.8576

    -3.19%

    Updated on 2024-12-23

    Open:0.8800
    Close:0.8576
    High:0.8908
    Low:0.8517
    Pre Close:0.8859
    Volume:453184.00
    Amount:392014.09
    Turnover:0.47%
    Shares:95.48M
    MarketCap:81.88M

    About Assertio Company

    Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

    Company Name: Assertio
    Company Address: 100 South Saunders Road,Suite 300
    Employees: 53
    Fiscar Year: 12-31
    IPO Date: 1997-12-02
    CIK: 1808665

    View all SEC Filings

    About

    Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
    Address:100 South Saunders Road,Suite 300

    Market Movers